Irregular periods and high testosterone can occur with PMOS, formerly called PCOS, but this combination does not establish the diagnosis by itself. Thyroid dysfunction, elevated prolactin, an adrenal enzyme disorder, medication exposure, and less common ovarian or adrenal conditions may change the explanation. Sometimes one condition accounts for the menstrual changes while a separate issue explains the androgen result.
Polyendocrine metabolic ovarian syndrome, or PMOS, is the new name for polycystic ovary syndrome. The terminology changed in 2026; both names refer to the same condition. This article focuses on what clinicians consider before attributing symptoms to PMOS. For the broader diagnostic and metabolic framework, see Ulta’s PMOS hormone and metabolic testing guide. [1]
Arrange prompt clinical evaluation if facial or body hair increases rapidly, the voice deepens, the clitoris enlarges, or other androgen-related changes develop quickly. Rapid progression deserves attention even when a laboratory result is only moderately elevated. A previous PMOS diagnosis should not automatically explain a new pattern.
Seek urgent medical care for severe pelvic pain, fainting, very heavy bleeding, or possible pregnancy accompanied by pain or bleeding. Sudden severe headache or new visual loss also requires urgent assessment. Routine direct-access testing should not delay that care.
Menstrual history, androgen symptoms, and laboratory results answer different questions. A missed period tells you that the usual bleeding pattern has changed. It does not identify why. A testosterone result describes a hormone concentration at one collection time; it does not identify the source or establish a syndrome.
Clinicians therefore consider the onset of symptoms, pregnancy possibility, medications, examination findings, and alternative diagnoses before confirming PMOS. Normal findings in one area do not make an unexplained abnormality elsewhere irrelevant. The purpose of evaluating PCOS mimics is to identify the explanation that best fits the whole presentation.
| Finding | Question it raises |
|---|---|
| A newly missed period | Could pregnancy explain the change? |
| Irregular cycles with abnormal thyroid results | Is thyroid dysfunction contributing to ovulatory problems? |
| Persistent prolactin elevation | Is a prolactin-related condition disrupting ovarian function? |
| Androgen symptoms with an elevated adrenal precursor | Does nonclassic congenital adrenal hyperplasia need confirmation? |
| Rapid or unusually severe androgen-related changes | Is an ovarian or adrenal source requiring expedited evaluation present? |
| Periods stop after substantial changes in eating, exercise, weight, or stress | Could reduced hypothalamic signaling be involved? |
| Missed periods with hot flashes or vaginal dryness before age 40 | Does premature ovarian insufficiency need evaluation? |
These are prompts for clinical assessment. They are not diagnostic rules, and several conditions can coexist.
Ask which method was used and whether the reference interval is appropriate for the patient. A reliable total testosterone test using mass spectrometry helps assess the low concentrations expected in women. Free testosterone and sex hormone-binding globulin, or SHBG, can add context when binding-protein effects complicate interpretation.
Unexpected results may need confirmation. Review units, collection timing, medicines, and possible hormone exposure before interpreting the flag.
Disclose prescribed testosterone, supplements, anabolic agents, and hormonal contraception. [2]
When pregnancy is possible, it belongs early in the evaluation, including for someone with historically irregular cycles or an established PMOS diagnosis. A blood hCG test may be appropriate when timing or the clinical situation makes a urine result uncertain. Pregnancy does not automatically explain a substantial androgen abnormality; that finding may still require separate assessment. [3]
Both an underactive and an overactive thyroid can affect menstruation. TSH, interpreted with free T4 when appropriate, helps assess this possibility. Fatigue, temperature intolerance, palpitations, bowel changes, or weight changes can provide additional context.
For example, high TSH with low free T4 warrants evaluation for hypothyroidism. [9] However, a mild thyroid abnormality should not automatically be assumed to explain every symptom or a substantial androgen elevation. Thyroid disease and PMOS can coexist. See Thyroid Blood Tests for a fuller explanation of these patterns. [3]
Hyperprolactinemia means persistently elevated prolactin. It can disrupt menstrual cycles, with or without unexpected breast-milk production. Medication effects, pregnancy, thyroid dysfunction, and pituitary conditions may contribute. [10]
A mildly elevated prolactin result may need confirmation because collection circumstances can temporarily affect the measurement. If elevation persists, the clinician may request laboratory assessment for macroprolactin, a less biologically active form, and consider pituitary imaging when indicated. One elevated result does not establish a prolactinoma, and a normal testosterone result does not make the prolactin finding unimportant. [3]
Nonclassic congenital adrenal hyperplasia, commonly related to partial 21-hydroxylase deficiency, can resemble PMOS through androgen symptoms and irregular cycles. It involves an inherited adrenal steroid-production pathway rather than the same underlying mechanism as PMOS.
The relevant screening measurement is 17-hydroxyprogesterone, often abbreviated 17-OHP. It is different from the progesterone test used when assessing ovulation. Early-morning collection is recommended, with menstrual-phase planning when feasible. An elevated screening result may require specialist-directed cosyntropin stimulation testing and additional adrenal measurements; it does not confirm the condition on its own. [4]
Cushing syndrome is uncommon. It becomes more relevant when menstrual or androgen symptoms accompany progressive features such as easy bruising, broad purple stretch marks, or muscle weakness. Medication history is essential because glucocorticoid exposure can produce similar findings.
When indicated, initial testing may use late-night salivary cortisol, 24-hour urinary free cortisol, or a dexamethasone suppression protocol. A random serum cortisol measurement does not adequately screen for Cushing syndrome. Timing, medicines, and test selection require clinician direction; an ordinary morning cortisol result should not provide false reassurance. See the Cushing syndrome testing guide for the dedicated evaluation pathway. [5]
Most androgen symptoms are not caused by a tumor. Nevertheless, rapid progression or unusually severe findings require evaluation beyond routine PMOS testing. Ovarian hyperthecosis, particularly after menopause, is another possible source of substantial androgen excess.
DHEA-S can provide information about adrenal androgen contribution, while testosterone and selected additional measurements help define the pattern. No single result reliably identifies the source. Clinical assessment may lead to targeted imaging or specialist investigation. Do not wait for an extreme laboratory value before seeking help for rapid virilization. [2]
Functional hypothalamic amenorrhea can occur when the brain reduces reproductive signaling in association with inadequate energy intake, substantial exercise, weight change, or psychological stress. The history matters more than assumptions based on appearance.
Clinicians may assess estradiol alongside FSH and LH after excluding pregnancy and other causes. Low-estrogen findings with low or inappropriately normal gonadotropins—the pituitary signals FSH and LH—can support this line of investigation. This pattern does not usually explain marked testosterone excess, so a discordant androgen result deserves separate review. Prolonged menstrual loss also raises bone-health concerns. [6]
Before age 40, irregular or absent periods with estrogen-deficiency symptoms should prompt consideration of premature ovarian insufficiency. Elevated FSH with the appropriate menstrual history is important; low estradiol can support the interpretation.
AMH is not the primary diagnostic test for this condition. Hormonal medicines can complicate assessment, and repeat testing may be needed when the diagnosis is uncertain. Like hypothalamic amenorrhea, ovarian insufficiency is mainly an alternative explanation for menstrual dysfunction, not a reason to dismiss substantial androgen excess. [7]
The appropriate workup starts with a consultation, menstrual history, medication review, and examination. Not everyone needs every test in the table. Selection depends on which explanations remain plausible.
| Clinical question | Tests that may help | Important limitation |
|---|---|---|
| Is pregnancy possible? | hCG | An early negative result may need reassessment; a result alone does not resolve pain or bleeding. |
| Is androgen excess confirmed? | Total testosterone by mass spectrometry, free testosterone, SHBG | Interpret with symptoms, medicines, reference intervals, and assay method. |
| Could thyroid or prolactin dysfunction explain the cycle changes? | TSH, free T4 when appropriate, prolactin | An abnormality may coexist with PMOS or another diagnosis. |
| Does an adrenal explanation need evaluation? | 17-hydroxyprogesterone; DHEA-S or androstenedione when indicated | Screening results may require specialist confirmation and do not independently locate a tumor. |
| Is hypothalamic dysfunction or ovarian insufficiency plausible? | FSH, LH, estradiol | Interpret the combination with menstrual history and medication exposure. |
| Does the clinical picture suggest cortisol excess? | Clinician-selected salivary or urinary cortisol testing, or dexamethasone suppression testing | These require specific protocols and are not routine additions for everyone with irregular cycles. |
For broader help with test selection across life stages, use Women’s Hormone Blood Tests. The Endocrine Disorders guide explains how ovarian, adrenal, thyroid, and pituitary findings connect.
The examples below illustrate reasoning, not instructions to diagnose yourself.
Yes. Combined oral contraception raises SHBG and suppresses androgen production, making untreated hormone status difficult to assess. Earlier cycle records and pretreatment results can therefore be valuable.
If biochemical androgen testing is essential, the international guideline describes a minimum three-month interval off the combined pill, with alternative contraception. This is a clinician-managed decision, not a preparation instruction to follow independently. Do not stop prescribed contraception or other medicines simply to obtain a different laboratory result. [8]
Ask which finding most needs clarification, whether any result requires confirmation, and whether imaging or specialist assessment is more useful than additional routine blood tests. Agree on when the results will be reviewed and what symptoms should prompt earlier contact.
After alternative causes are assessed, clinicians apply the appropriate diagnostic framework. Adult and adolescent criteria differ. In adolescents, both ovulatory dysfunction and hyperandrogenism are required; AMH and ultrasound are not recommended for diagnosis. [8]
Once the diagnosis is established, reproductive goals and metabolic risk need coordinated follow-up. Continue with the main PMOS guide for the overall framework and PMOS and diabetes risk for the separate glucose-testing question.
No. It must be interpreted with symptoms, menstrual history, medicines, test method, and other findings. The source may require further evaluation.
Yes. Finding one condition does not remove the need to investigate findings it does not adequately explain.
No. The clinician should select tests according to the presentation. Pregnancy, thyroid, prolactin, adrenal, and ovarian-pituitary questions do not require identical workups.
No. Ultrasound is one part of selected evaluations. It does not resolve every hormonal cause of irregular periods, and PMOS may be diagnosed without ovarian morphology when the other required features are present.
Ulta provides access to laboratory testing that can support a discussion with a qualified healthcare professional. Begin with the question that needs answering, follow the instructions for the exact test selected, and arrange clinical review of the findings. Imaging, dynamic hormone protocols, and specialist assessment may be needed beyond a routine laboratory order.
This article provides general education. Laboratory results do not independently establish PMOS or another diagnosis and should not be used to start, stop, or change treatment without professional guidance.
| Category | Tests with verified Ulta links | Role |
|---|---|---|
| Androgen assessment | Testosterone, Total, MS; Testosterone, Free (Dialysis) and Total, MS; Sex Hormone-Binding Globulin (SHBG) | Assess testosterone and binding-protein context. The combined free/total test already includes total testosterone. |
| Additional androgen evaluation | DHEA-S; Androstenedione | Conditional testing when additional androgen information is needed. |
| Pregnancy evaluation | hCG, Total, Quantitative | Assess pregnancy when relevant to missed periods. |
| Thyroid evaluation | TSH; T4, Free | Evaluate thyroid contributions to menstrual changes. |
| Prolactin evaluation | Prolactin | Assess prolactin-related menstrual dysfunction. |
| Nonclassic congenital adrenal hyperplasia screening | 17-Hydroxyprogesterone, LC/MS/MS | Targeted screening; abnormal findings may require specialist confirmation. |
| Ovarian-pituitary evaluation | Follicle-Stimulating Hormone (FSH); Luteinizing Hormone (LH); Estradiol | Interpret together when investigating ovarian insufficiency or hypothalamic dysfunction. |
| Conditional cortisol evaluation | Cortisol, Saliva, 2 Samples; Cortisol, Free, 24-Hour Urine with Creatinine | Clinician-directed evaluation when findings suggest cortisol excess. |
| Tests mentioned for distinctions or limitations | Anti-Müllerian Hormone (AMH); Progesterone | AMH is discussed as insufficient alone for diagnosis; progesterone is distinguished from 17-hydroxyprogesterone. |
| Health Area | Connection | |
|---|---|---|
| 1 | Women’s Health Tests | Menstrual and reproductive health |
| 2 | Reproductive Hormone Tests | Androgens and ovarian-pituitary signaling |
| 3 | Thyroid Tests | Thyroid-related menstrual changes |
| 4 | Pituitary Disorders | Prolactin and pituitary evaluation |
| 5 | Pregnancy and Fertility Tests | Pregnancy exclusion and fertility questions |
| 6 | Cushing Syndrome | Selected evaluation for cortisol excess |
Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)
